Involvement of sympathetic efferents but not capsaicin-sensitive afferents in nociceptin-mediated dual control of rat synovial blood flow

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 284, Issue 6 53-6, 2003, Pages

  McDougall, Jason J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Neurogenic inflammation; Neuropeptides; Orphanin FQ; Sympathetic nervous system

Indexed keywords

CAPSAICIN; GUANETHIDINE; NALOXONE; NEUROPEPTIDE; NOCICEPTIN; OPIATE RECEPTOR; PHENTOLAMINE; URETHAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRALGIA; ARTICLE; BLOOD FLOW; CONTROLLED STUDY; EFFERENT NERVE; JOINT CAPSULE; KNEE; LASER DOPPLER FLOWMETRY; MALE; NEUROGENIC INFLAMMATION; NONHUMAN; NONMYELINATED NERVE; PRIORITY JOURNAL; RAT; SYMPATHETIC NERVE; SYNOVIUM; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION; VASOMOTOR REFLEX;

EID: 0038176786     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00733.2002     Document Type: Article

References (41)

1. Ackermann PW, Spetea M, Nylander I, Ploj K, Ahmed M, and Kreicbergs A. An opioid system in connective tissue. A study of achilles tendon in the rat. J Histochem Cytochem 49: 1387-1396, 2001.
2. Andoh T, Itoh M, and Kuraishi Y. Nociceptin gene expression in rat dorsal root ganglia induced by peripheral inflammation. Neuroreport 8: 2793-2796, 1997.
3. Armstead WM. Nociceptin/orphanin FQ dilates pial arteries by K(ATP) and K(ca) channel activation. Brain Res 835: 315-323, 1999.
4. Arndt ML, Wu D, Soong Y, and Szeto HH. Nociceptin/orphanin FQ increases blood pressure and heart rate via sympathetic activation in sheep. Peptides 20: 465-470, 1999.
5. Bigoni R, Giuliani S, Calo G, Rizzi A, Guerrini R, Salvadori S, Regoli D, and Maggi CA. Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies. Naunyn Schmiedebergs Arch Pharmacol 359: 160-167, 1999.
6. Binder W and Walker JS. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis. Br J Pharmacol 124: 647-654, 1998.
7. Brooks H, Elton CD, Smart D, Rowbotham DJ, McKnight AT, and Lambert DG. Identification of nociceptin in human cerebrospinal fluid: comparison of levels in pain and non-pain states. Pain 78: 71-73, 1998.
8. Champion HC, Bivalacqua TJ, Friedman DE, Zadina JE, Kastin AJ, and Kadowitz PJ. Nitric oxide release mediates vasodilator responses to endomorphin 1 but not nociceptin/OFQ in the hindquarters vascular bed of the rat. Peptides 19: 1595-1602, 1998.
9. Champion HC and Kadowitz PJ. Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the rat. Life Sci 60: PL241-PL245, 1997.
10. Chen Y, Fan Y, Liu J, Mestek A, Tian M, Kozak CA, and Yu L. Molecular cloning, tissue distribution and chromosomal localization of a novel member of the opioid receptor gene family. FEBS Lett 347: 279-283, 1994.
11. Darland T, Heinricher MM, and Grandy DK. Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more. Trends Neurosci 21: 215-221, 1998.
12. Evans CJ, Keith DE Jr, Morrison H, Magendzo K, and Edwards RH. Cloning of a delta opioid receptor by functional expression. Science 258: 1952-1955, 1992.
13. Ferrell WR, Lam F, and Montgomery I. Differences in the axon composition of nerves supplying the rat knee joint following intra-articular injection of capsaicin. Neurosci Lett 141: 259-261, 1992.
14. Giuliani S, Lecci A, and Maggi CA. Nociceptin and neurotransmitter release in the periphery. Peptides 21: 977-984, 2000.
15. Giuliani S, Tramontana M, Lecci A, and Maggi CA. Effect of nociceptin on heart rate and blood pressure in anaesthetized rats. Eur J Pharmacol 333: 177-179, 1997.
16. Goda Y and Mutneja M. Memory mechanisms: The nociceptin connection. Curr Biol 8: R889-R891, 1998.
17. Green PG and Levine JD. Delta- and kappa-opioid agonists inhibit plasma extravasation induced by bradykinin in the knee joint of the rat. Neuroscience 49: 129-133, 1992.
18. Grond S, Gabriel A, Pietruck C, Yu LC, Xie GX, and Pierce Palmer P. Bi-directional modulation of 5-hydroxytryptamine induced plasma extravasation in the rat knee joint by nociceptin. Neuroscience 103: 1085-1092, 2001.
19. Guerrini R, Calo G, Rizzi A, Bigoni R, Bianchi C, Salvadori S, and Regoli D. A new selective antagonist of the nociceptin receptor. Br J Pharmacol 123: 163-165, 1998.
20. Gyires K, Budavari I, Furst S, and Molnar I. Morphine inhibits the carrageenan-induced oedema and the chemoluminescence of leucocytes stimulated by zymosan. J Pharm Pharmacol 37: 100-104, 1985.
21. Inoue M, Kobayashi M, Kozaki S, Zimmer A, and Ueda H. Nociceptin/orphanin FQ-induced nociceptive responses through substance P release from peripheral nerve endings in mice. Proc Natl Acad Sci USA 95: 10949-10953, 1998.
22. Joris J, Costello A, Dubner R, and Hargreaves KM. Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia. Pain 43: 95-103, 1990.
23. Karimian SM, McDougall JJ, and Ferrell WR. Neuropeptidergic and autonomic control of the vasculature of the rat knee joint revealed by laser Doppler perfusion imaging. Exp Physiol 80: 341-348, 1995.
24. Levine JD, Moskowitz MA, and Basbaum AI. The contribution of neurogenic inflammation in experimental arthritis. J Immunol 135: 843s-847s, 1985.
25. Li S, Zhu J, Chen C, Chen YW, Deriel JK, Ashby B, and Liu-Chen LY. Molecular cloning and expression of a rat kappa opioid receptor. Biochem J 295: 629-633, 1993.
26. McDougall JJ, Ferrell WR, and Bray RC. Spatial variation in sympathetic influences on the vasculature of the synovium and medial collateral ligament of the rabbit knee joint. J Physiol 503: 435-443, 1997.
27. 1 receptors in nociceptin-induced modulation of rat knee joint mechanosensitivity. Exp Brain Res 137: 249-253, 2001.
28. McDougall JJ, Karimian SM, and Ferrell WR. Alteration of substance P-mediated vasodilatation and sympathetic vasoconstriction in the rat knee joint by adjuvant-induced inflammation. Neurosci Lett 174: 127-129, 1994.
29. McDougall JJ, Pawlak M, Hanesch U, and Schmidt RF. Peripheral modulation of rat knee joint afferent mechanosensitivity by nociceptin/orphanin FQ. Neurosci Lett 288: 123-126, 2000.
30. Meunier JC. Nociceptin/orphanin FQ and the opioid receptorlike ORL1 receptor. Eur J Pharmacol 340: 1-15, 1997.'
31. Mollereau C, Parmentier M, Mailleux P, Butour JL, Moisand C, Chalon P, Caput D, Vassart G, and Meunier JC. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett 341: 33-38, 1994.
32. Neal CR Jr, Mansour A, Reinscheid R, Nothacker HP, Civelli O, and Watson SJ Jr. Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J Comp Neurol 406: 503-547, 1999.
33. Norris AA, Leeson ME, Jackson DM, and Holroyde MC. Modulation of neurogenic inflammation in rat trachea. Pulm Pharmacol 3: 180-184, 1990.
34. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJ Jr, and Civelli O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 270: 792-794, 1995.
35. Riedl M, Shuster S, Vulchanova L, Wang J, Loh HH, and Elde R. Orphanin FQ/nociceptin-immunoreactive nerve fibers parallel those containing endogenous opioids in rat spinal cord. Neuroreport 7: 1369-1372, 1996.
36. Rossi GC, Leventhal L, and Pasternak GW. Naloxone sensitive orphanin FQ-induced analgesia in mice. Eur J Pharmacol 311: R7-R8, 1996.
37. Ruscheweyh R and Sandkuhler J. Bidirectional actions of nociceptin/orphanin FQ on A delta-fibre-evoked responses in rat superficial spinal dorsal horn in vitro. Neuroscience 107: 275-281, 2001.
38. Schuligoi R, Amann R, Angelberger P, and Peskar BA. Determination of nociceptin-like immunoreactivity in the rat dorsal spinal cord. Neurosci Lett 224: 136-138, 1997.
39. Wang JB, Imai Y, Eppler CM, Gregor P, Spivak CE, and Uhl GR. Mu opiate receptor: cDNA cloning and expression. Proc Natl Acad Sci USA 90: 10230-10234, 1993.
40. Wang JB, Johnson PS, Imai Y, Persico AM, Ozenberger BA, Eppler CM, and Uhl GR. cDNA cloning of an orphan opiate receptor gene family member and its splice variant. FEBS Lett 348: 75-79, 1994.
41. Wilson JL, Nayanar V, and Walker JS. The site of antiarthritic action of the kappa-opioid, U-50, 488H, in adjuvant arthritis: importance of local administration. Br J Pharmacol 118: 1754-1760, 1996.